Catalysts
BIO Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
BIOBio-Rad Laboratories, Inc.
Healthcare / Medical - Devices
Leader
Sector Leader
Latest quote
- Momentum79
- Value80
- Quality61
- Risk resilience74
- Sentiment—
Stock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 79/100 and sentiment — before the next covered event.
Updated Nov 18, 2026 · Sentiment 25.41%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | — | $2.23 | $2.65 | +18.8% | $649.94M | $656.4M |
| Aug 4, 2026 | — | $1.75 | $2.62 | +49.7% | $623.99M | $651M |
| Apr 30, 2026 | — | $1.97 | $1.89 | -4.1% | $589.91M | $592.1M |
| Feb 12, 2026 | — | $2.57 | $2.51 | -2.3% | $688.81M | $693.2M |
| Oct 29, 2025 | — | $2.30 | $2.26 | -1.7% | $694.64M | $653M |
| Jul 31, 2025 | — | $1.93 | $2.61 | +35.2% | $633.81M | $651.6M |
| May 1, 2025 | — | $1.73 | $2.54 | +46.8% | $573.23M | $585.4M |
| Feb 13, 2025 | — | $2.86 | $2.90 | +1.4% | $679.75M | $667.48M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Is Bio-Rad Laboratories, Inc. (BIO) an Activist Investor Target With Significant Hidden Value
We have just published our list of the 10 Activist Target Stocks with High Cash and Low Valuations, with Bio-Rad Laboratories ranked 8th on the list. Bio-Rad Laboratories, Inc.
Related Links
BIO Catalysts FAQ
What are the next catalysts for BIO stock?
BIO's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move BIO stock?
Upcoming events that could move BIO include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could BIO's next earnings report affect the stock?
BIO's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive BIO stock higher?
BIO could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt BIO stock?
BIO could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.